Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cybersickness imAgiNg Olfactory Evocation

NCT: NCT05308433 · COMPLETED

NCT IDNCT05308433
StatusCOMPLETED
Start Date2022-04-13
Completion2022-10-26
SponsorCentral Hospital, Nancy, France (OTHER)
First posted
Last updated

Brief Summary

The aim of this study is to, using fMRI, compare brain activations during olfactory imagery induced by different visual supports (words, pictures, colors and colored arrangements) in healthy subjects. This will allow us to choose the best olfactory imagery facilitator and to assess its effect on cybersickness.

Frequently Asked Questions

What is Cybersickness imAgiNg Olfactory Evocation?

Cybersickness imAgiNg Olfactory Evocation is a clinical trial registered under NCT05308433. Current status: COMPLETED.

What is the status of NCT05308433?

The current status of NCT05308433 (Cybersickness imAgiNg Olfactory Evocation) is: COMPLETED.

When did Cybersickness imAgiNg Olfactory Evocation start?

Cybersickness imAgiNg Olfactory Evocation started on 2022-04-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.